Skip to content

Clinical value of procalcitonin and C-reactive protein in early prediction of infectious complications after laparoscopic gastric cancer surgery: a multicenter prospective study

Clinical value of procalcitonin and C-reactive protein in early prediction of infectious complications after laparoscopic gastric cancer surgery: a multicenter prospective study

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100055001
Enrollment
Unknown
Registered
2021-12-30
Start date
2020-12-01
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Gold Standard:''Expert Consensus on Standardization of Diagnosis Grades for Postoperative Complications in Gastrointestinal Tumor Surgery in China''
&#32
protein

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Those who voluntarily participated in this study and signed a written informed consent; 2. Those aged 18-75 years; 3. Those diagnosed with gastric cancer by gastroscopic biopsy before surgery; 4. Patients with no distant metastasis confirmed by imaging before surgery; 5. Postoperative pathology confirmed complete tumor resection.

Exclusion criteria

Exclusion criteria: 1. Patients who are pregnant, lactating or menstruating; 2. Severe heart failure, chronic obstructive pulmonary disease and other underlying diseases; 3. Patients with severe infection before surgery; 4. Those who have participated in other clinical trials within 3 months; 5. In view of a certain disease or situation, the investigator believes that the subject may have a significant risk, may interfere with the research results, or may seriously affect the subject's participation in this research.

Design outcomes

Primary

MeasureTime frame
Infectious complication;Procalcitonin;C-reactive protein;Sensitivity;Specificity;Negative predictive value, positive predictive value;

Secondary

MeasureTime frame
Blood routine;

Countries

China

Contacts

Public ContactTao Kaixiong

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

kaixiongtao@hust.edu.cn+86 15002740874

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026